会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明申请
    • Variable gain amplifier
    • 可变增益放大器
    • US20060012434A1
    • 2006-01-19
    • US10526436
    • 2002-09-19
    • Yoshinori TakahashiHisato Ishimoto
    • Yoshinori TakahashiHisato Ishimoto
    • H03G3/30
    • H03G7/00
    • A variable gain amplifier includes a plurality of element circuits each having an output current that increases at a constant rate with a change in a variable control voltage, voltages that increase in steps of the change being respectively supplied to the plurality of element circuits as their reference voltages and the control voltage being supplied to each of the plurality of element circuits, multipliers for multiplying the output currents from the plurality of element circuits by one another, and an amplifier for carrying out a variable gain amplification based on an output current from the multipliers. The variable gain amplifier can suppress any change in the characteristics thereof due to temperature compensation of the characteristics and variations in manufacturing of transistors, and carry out a linear gain control operation on the control voltage when the gain is expressed in a logarithm.
    • 可变增益放大器包括多个元件电路,每个元件电路具有随着可变控制电压的变化而以恒定速率增加的输出电流,以改变步长增加的电压分别提供给多个元件电路作为参考 提供给多个元件电路中的每一个的电压和控制电压,用于将来自多个元件电路的输出电流彼此相乘的乘法器和用于基于来自乘法器的输出电流执行可变增益放大的放大器 。 可变增益放大器可以抑制由于特性的温度补偿和晶体管制造的变化而引起的特性变化,并且当增益以对数表示时,对控制电压进行线性增益控制操作。
    • 2. 发明授权
    • &pgr;/2 phase shifter
    • pi / 2移相器
    • US06815993B1
    • 2004-11-09
    • US10110203
    • 2002-04-17
    • Hisato IshimotoYoshinori Takahashi
    • Hisato IshimotoYoshinori Takahashi
    • H03H1116
    • H03H11/22H03D7/1433H03D7/1441H03D7/165H03H7/21
    • In a &pgr;/2 phase shifter, first and second signals and first and second inverted signals are produced based on input signals. The first and second signals have the same amplitude and are out of phase from each other, and the first and second inverted signals respectively correspond to the first and second signals with their respective phases inverted. A first output signal is produced by adding the first signal and the second signal, and a second output signal is produced by adding the first signal and the second inverted signal. Since the first and second signals have the same amplitude, the first output signal and the second output signal respectively correspond to diagonal lines of a rhombus formed by a vector representing the first signal and a vector representing the second signal. Accordingly, the phase difference between the first and second output signals of the &pgr;/2 phase shifter is accurately set to &pgr;/2 even when the phase difference between the first and second signals is not &pgr;/2.
    • 在π/ 2移相器中,基于输入信号产生第一和第二信号以及第一和第二反相信号。 第一信号和第二信号具有相同的幅度并且彼此异相,并且第一和第二反相信号分别对应于其相应相位反转的第一和第二信号。 通过将第一信号和第二信号相加来产生第一输出信号,并且通过将第一信号和第二反相信号相加来产生第二输出信号。 由于第一和第二信号具有相同的幅度,所以第一输出信号和第二输出信号分别对应于由表示第一信号的矢量和表示第二信号的矢量形成的菱形的对角线。 因此,即使当第一和第二信号之间的相位差不是pi / 2时,pi / 2移相器的第一和第二输出信号之间的相位差被精确地设置为pi / 2。
    • 6. 发明授权
    • Pyrazolothiazole compound
    • 吡唑并噻唑化合物
    • US08530504B2
    • 2013-09-10
    • US12900026
    • 2010-10-07
    • Kogyoku ShinTaro TerauchiYoshinori TakahashiMinako HashizumeKunitoshi TakedaKodo ShikataAkira Inomata
    • Kogyoku ShinTaro TerauchiYoshinori TakahashiMinako HashizumeKunitoshi TakedaKodo ShikataAkira Inomata
    • A61K31/429A61P25/24
    • C07D513/04
    • A compound represented by the formula (I) or pharmacologically acceptable salt thereof exhibits an excellent CRF receptor antagonism wherein X is a nitrogen atom or CH; R1 is -A11-A12; A11 is a single bond or a C1-6 alkylene group; A12 is a hydrogen atom, a C1-6 alkyl group or a C3-6 cycloalkyl group, etc.; R2 is -A21-A22; A21 is a single bond or a C1-6 alkylene group; A22 is a hydrogen atom, a C1-6 alkyl group, a C3-6 cycloalkyl group, a non-aromatic heterocyclic group, or a heteroaryl group, etc.; R3 is a C1-6 alkyl group, a C3-6 cycloalkyl group, a C1-6 alkoxy group, a C3-6 cycloalkoxy C1-6 alkyl group, di-C1-6 alkyl amino group, a halogen atom, a cyano group, a formyl group, or a carboxyl group, etc; R4 is a hydrogen atom or a C1-6 alkoxy group; R5 is a halogen atom, a C1-6 alkyl group, or a C1-6 alkoxy group; R6 is a hydrogen atom, a C1-6 alkyl group, a C1-6 alkoxy group, a C1-6 alkylthio group, or a C1-6 alkyl sulfinyl group etc.; and R7 is a C1-6 alkyl group, a C1-6 alkoxy group, or a C1-6 alkylthio group.
    • 由式(I)表示的化合物或其药理学上可接受的盐表现出优异的CRF受体拮抗作用,其中X为氮原子或CH; R1为-A11-A12; A11是单键或C1-6亚烷基; A12是氢原子,C1-6烷基或C3-6环烷基等; R2为-A21-A22; A21是单键或C1-6亚烷基; A22为氢原子,C1-6烷基,C3-6环烷基,非芳族杂环基或杂芳基等; R3是C1-6烷基,C3-6环烷基,C1-6烷氧基,C3-6环烷氧基C1-6烷基,二C1-6烷基氨基,卤素原子,氰基 ,甲酰基或羧基等; R4是氢原子或C1-6烷氧基; R5是卤素原子,C1-6烷基或C1-6烷氧基; R6是氢原子,C1-6烷基,C1-6烷氧基,C1-6烷硫基或C1-6烷基亚磺酰基等; 且R 7为C 1-6烷基,C 1-6烷氧基或C 1-6烷硫基。